Form 4 Tracker
Howard G. Welgus

Director · 6 filings · Latest: Jun 15, 2026

Arcutis Biotherapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARQT
Howard G. WelgusDirectorJun 17, 2026
Sale
$25.67635$16.3K37,743
ARQT
Howard G. WelgusDirectorJun 15, 2026
Sale
$24.414,096$100.0K38,378
ARQT
Howard G. WelgusDirectorJun 15, 2026
Option Exercise
$7.934,096$32.5K42,474
ARQT
Howard WelgusJun 17, 2026
Proposed Sale
$25.67635$16.3K
ARQT
Howard WelgusJun 15, 2026
Proposed Sale
$24.414,096$100.0K
ARQT
Howard G. WelgusDirectorMay 1, 2026
Sale
$22.997,144$164.2K32,600
ARQT
Howard WelgusMay 1, 2026
Proposed Sale
$22.997,144$164.2K
ARQT
Howard G. WelgusDirectorApr 1, 2026
Sale
$23.8810,000$238.8K39,744
ARQT
Howard WelgusApr 1, 2026
Proposed Sale
$23.8810,000$238.8K
ARQT
Howard G. WelgusDirectorMar 2, 2026
Sale
$25.6510,000$256.5K49,744
ARQT
Howard WelgusMar 2, 2026
Proposed Sale
$25.6510,000$256.5K
ARQT
Howard G. WelgusDirectorFeb 2, 2026
Sale
$25.0510,000$250.5K59,744
ARQT
Howard WelgusFeb 2, 2026
Proposed Sale
$25.0510,000$250.5K
ARQT
Howard WelgusJan 2, 2026
Proposed Sale
$28.9610,000$289.6K
ARQT
Howard WelgusDec 1, 2025
Proposed Sale
$30.2110,000$302.1K
ARQT
Howard WelgusNov 3, 2025
Proposed Sale
$25.2710,000$252.7K
ARQT
Howard WelgusOct 1, 2025
Proposed Sale
$18.9210,000$189.2K
ARQT
Welgus Howard G.Sep 2, 2025
Proposed Sale
$15.6110,000$156.1K
ARQT
Welgus Howard G.Aug 1, 2025
Proposed Sale
$14.3010,000$143.0K
ARQT
Welgus Howard G.Jul 1, 2025
Proposed Sale
$13.849,208$127.4K

Page 1 of 2

Next →